PureTech Health (PRTC) Earnings Analysis

PureTech Health (PRTC) next reports earnings on 2026-08-27, consensus EPS -1.16 USD. Last quarter (2026-04-29) it missed with EPS -26.9 USD vs -1.94 USD est (-1286.6%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -0.60.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does PRTC next report earnings?

Next earnings date2026-08-27
Consensus EPS estimate-1.16 USD
Revenue estimate0.02B

PRTC earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-29-26.9 USD-1.94 USD-1286.6%Miss
2025-08-28-1.85882 USD-2.04 USD+8.9%Beat
2025-04-300.3533 USD-2.83 USD+112.5%Beat
2024-08-28-0.15491 USD-3.03 USD+94.9%Beat

Beat rate: 3/4 (75%) over reported quarters with consensus data.

PRTC valuation and analyst view

Trailing P/E-0.60
Trailing EPS-45.36674 USD
Price / book0.13
Dividend yield0.00%
Market cap0.42B
Analyst consensusBuy (2 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is PureTech Health (PRTC)'s next earnings date?

PureTech Health is next scheduled to report on 2026-08-27, with a consensus EPS estimate of -1.16 USD and revenue estimate of 0.02B.

Did PRTC beat earnings last quarter?

In its 2026-04-29 report, PRTC posted EPS of -26.9 USD versus a -1.94 USD estimate — a miss of 1286.6%.

What is PRTC's earnings track record?

Over the last 4 reported quarters with consensus data, PRTC beat estimates 3 times (75%).

What is PRTC's current P/E ratio and EPS?

PRTC trades at a trailing P/E of -0.60 on trailing EPS of -45.36673780400897 USD.

What do analysts rate PRTC?

Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell).